Clinical Trials Logo

Chronic Kidney Disease Stage 1 clinical trials

View clinical trials related to Chronic Kidney Disease Stage 1.

Filter by:
  • None
  • Page 1

NCT ID: NCT05225454 Active, not recruiting - Metabolic Syndrome Clinical Trials

The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques

Start date: March 3, 2021
Phase:
Study type: Observational [Patient Registry]

Used multi-year health examination member profile by multi-algorithms technology, to find comprehensive key hazard factors or important high-risk group components for metabolic syndrome and chronic kidney disease or more common chronic diseases.

NCT ID: NCT05198284 Recruiting - Clinical trials for Chronic Kidney Diseases

Prospective Decision Impact Clinical Utility Trial of KidneyIntelX

Start date: November 1, 2021
Phase:
Study type: Observational

The clinical utility trial is designed to evaluate how the results of KidneyIntelX test / platform impacts on the clinical management of type 2 diabetes patients identified as increased risk for rapid kidney function decline within 5-years.

NCT ID: NCT04960514 Recruiting - Clinical trials for Diabetic Kidney Disease

Prospective Decision Impact Trial of KidneyIntelX

Start date: November 22, 2021
Phase:
Study type: Observational

The current trial is designed to evaluate how the results of KidneyIntelX test / platform impacts on the clinical management of type 2 diabetes patients identified as increased risk for rapid kidney function decline within 5-years.

NCT ID: NCT04617431 Completed - Clinical trials for Chronic Kidney Disease stage4

Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients

Start date: January 13, 2019
Phase: N/A
Study type: Interventional

Aim: By application of wearable devices and health management platform to build self-management model in CKD patients and analyze the cost of healthcare. Material and Methods: The investigators plan to recruit 60 CKD patients as trial subjects. The intervention group is composed of 30 participants, and the control group 30 participants. The intervention group received intervention with wearable devices and health management platform for 90 days. Patients record diet diary by a smartphone application, and their exercise-related data are collected by wearable devices. Then, all the collected information will be upload to health management platform. The investigators also create a LINE group to encourage exercise in the experimental group. The investigators compare the scores of self-management sheet and physical and laboratory examinations before and after the intervention. The investigators also analyze the cost of healthcare within 180 days.

NCT ID: NCT01561222 Not yet recruiting - Clinical trials for Chronic Kidney Disease Stage 2

Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2

Start date: July 2015
Phase: Phase 4
Study type: Interventional

Vitamin D Supplement in patients with CKD stage 1 and 2 may change osteoprotegin expression so as to produce beneficial effects of cardiovascular、bone metabolism and CKD progression.